No abstract available
MeSH terms
-
Cost-Benefit Analysis / economics
-
Diabetes Mellitus, Type 2 / economics
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / prevention & control
-
Diabetic Retinopathy / economics*
-
Diabetic Retinopathy / epidemiology
-
Diabetic Retinopathy / prevention & control*
-
Humans
-
Mass Screening / economics*
-
Quality-Adjusted Life Years
-
Risk Factors
-
United States / epidemiology